Heron Therapeutics enters manufacturing/supply deal with Patheon, commits to 38,400 kg through 2026

HERON THERAPEUTICS, INC. /DE/

Framework Agreement with Patheon Austria GmbH & Co KG, a Thermo Fisher unit, for manufacturing and supply of products.
Heron commits to purchase 38,400 kg of Products through December 31, 2026.
Prior agreements terminated; obligations replaced under amended Manufacturing and Supply Agreement.
Patheon to continue stability studies and provide warehousing services for the Products.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.